EMDR in the Treatment of Specific Phobia.

February 24, 2017 updated by: Norwegian University of Science and Technology

EMDR (Eye Movement Desensitization and Reprocessing) in the Treatment of Specific Phobia. A Randomised Controlled Trial.

The purpose for this study is to determine whether EMDR is effective in the treatment of specific (animal) phobia.

Study Overview

Status

Withdrawn

Conditions

Intervention / Treatment

Detailed Description

Aims: To test the hypothesis that one session EMDR is more effective for the treatment of specific (animal) phobia than relaxation immediately after treatment and at follow-up. Secondly to test whether an additional one-session exposure therapy offered to both treatment groups (EMDR patients and relaxation patients) improves outcome in the EMDR-group and results in equal outcome for both treatment groups.

Study Type

Interventional

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 65 years (ADULT, OLDER_ADULT, CHILD)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients with Specific (Animal) Phobia

Exclusion Criteria:

  • Current or past psychotic disorder
  • Current substance dependence or abuse
  • Serious physical illness
  • Active suicidal behavior
  • Bipolar affective disorder
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: EMDR
The experimental group was treated for animal phobia by EMDR, control group received an attention placebo (relaxation plus breathing exercises). Afterwards, both groups were treated by exposure therapy (therapy of choice for animal phobia).
Other: EMDR (Eye Movement Desensitization and Reprocessing)
Psychotherapy which is approved for PTSD.
Other: Exposure therapy
All participants in the study received exposure therapy som second treatment. Exposure therapy is the therapy of choice for animal phobia.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Behavioral Approach Test towards the feared animal.
Time Frame: Before and after each treatment
Before and after each treatment

Secondary Outcome Measures

Outcome Measure
Time Frame
Scores on self-report questionnaires on phobic symptoms
Time Frame: Before and after both treatments
Before and after both treatments
Neuropsychological function
Time Frame: Before first treatment, some measures also before second treatment
Before first treatment, some measures also before second treatment
Cognitive strategies
Time Frame: Before both treatments
Before both treatments

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Norwegian University of Science and Technology

Collaborators

St. Olavs Hospital

Investigators

  • Principal Investigator: Ludger Kaiser, Doctor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2004

Primary Completion (Actual)

September 1, 2004

Study Completion (Actual)

September 1, 2004

Study Registration Dates

First Submitted

September 10, 2005

First Submitted That Met QC Criteria

September 10, 2005

First Posted (Estimate)

September 16, 2005

Study Record Updates

Last Update Posted (Actual)

February 28, 2017

Last Update Submitted That Met QC Criteria

February 24, 2017

Last Verified

February 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EPLK-2004

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe